Gene expression profiling in hearts of diabetic mice uncovers a potential role of estrogen-related receptor γ in diabetic cardiomyopathy

Molecular and Cellular Endocrinology

Volumn 430, Issue , 2016, Pages 77-88

  Lasheras, Jaime ^a   Vilà, Maria ^a   Zamora, Mònica ^b,c   Riu, Efrén ^a,d   Pardo, Rosario ^a   Poncelas, Marcos ^a   Cases, Ildefonso ^e   Ruiz Meana, Marisol ^a   Hernández, Cristina ^a,d   Feliu, Juan E ^a   Simó, Rafael ^a,d   García Dorado, David ^a   Villena, Josep A ^a,d  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e Institute of Predictive and Personalized Medicine of Cancer IMPPC   (Spain)

Author keywords

Diabetes; Estrogen related receptors; Fatty acid oxidation; Lipid metabolism; Orphan nuclear receptor; Transcriptional regulation of gene expression

Indexed keywords

ESTROGEN RELATED RECEPTOR GAMMA; PALMITIC ACID; STEROID RECEPTOR; UNCLASSIFIED DRUG; ESRRG PROTEIN, MOUSE; ESTROGEN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; DB/DB MOUSE; DIABETIC CARDIOMYOPATHY; FATTY ACID OXIDATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HEART MUSCLE CONTRACTILITY; LIPID OXIDATION; MALE; MOUSE; MUSCLE HYPERTROPHY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; ANIMAL; CARDIAC MUSCLE; CARDIOMEGALY; DIAGNOSTIC IMAGING; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; LIPID METABOLISM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROMOTER REGION;

ANIMALS; CARDIOMEGALY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; LIPID METABOLISM; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; PPAR ALPHA; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN;

EID: 84964331029     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.04.004     Document Type: Article

References (46)

1. Aasum, E., Hafstad, A.D., Severson, D.L., Larsen, T.S., Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52 (2003), 434–441.
2. Alaynick, W.A., Kondo, R.P., Xie, W., He, W., Dufour, C.R., Downes, M., et al. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab. 6 (2007), 13–24.
3. Ares-Carrasco, S., Picatoste, B., Camafeita, E., Carrasco-Navarro, S., Zubiri, I., Ortiz, A., et al. Proteome changes in the myocardium of experimental chronic diabetes and hypertension: role of PPARalpha in the associated hypertrophy. J. Proteomics 75 (2011), 1816–1829.
4. Belke, D.D., Larsen, T.S., Gibbs, E.M., Severson, D.L., Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am. J. Physiol. Endocrinol. Metab. 279 (2000), E1104–E1113.
5. Bertoni, A.G., Tsai, A., Kasper, E.K., Brancati, F.L., Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 26 (2003), 2791–2795.
6. Boudina, S., Sena, S., O'Neill, B.T., Tathireddy, P., Young, M.E., Abel, E.D., Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112 (2005), 2686–2695.
7. Boudina, S., Sena, S., Theobald, H., Sheng, X., Wright, J.J., Hu, X.X., et al. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56 (2007), 2457–2466.
8. Buchanan, J., Mazumder, P.K., Hu, P., Chakrabarti, G., Roberts, M.W., Yun, U.J., et al. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146 (2005), 5341–5349.
9. Bugger, H., Abel, E.D., Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin. Sci. Lond 114 (2008), 195–210.
10. Bugger, H., Abel, E.D., Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57 (2014), 660–671.
11. Bugger, H., Chen, D., Riehle, C., Soto, J., Theobald, H.A., Hu, X.X., et al. Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. Diabetes 58 (2009), 1986–1997.
12. Burkart, E.M., Sambandam, N., Han, X., Gross, R.W., Courtois, M., Gierasch, C.M., et al. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J. Clin. Invest. 117 (2007), 3930–3939.
13. Carley, A.N., Semeniuk, L.M., Shimoni, Y., Aasum, E., Larsen, T.S., Berger, J.P., et al. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function. Am. J. Physiol. Endocrinol. Metab. 286 (2004), E449–E455.
14. Claycomb, W.C., Lanson, N.A. Jr., Stallworth, B.S., Egeland, D.B., Delcarpio, J.B., Bahinski, A., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 2979–2984.
15. Cresci, S., Huss, J.M., Beitelshees, A.L., Jones, P.G., Minton, M.R., Dorn, G.W., et al. A PPARalpha promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetes. PLoS One, 5, 2010, e12584.
16. Daniels, A., van Bilsen, M., Janssen, B.J., Brouns, A.E., Cleutjens, J.P., Roemen, T.H., et al. Impaired cardiac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural, remodelling. Acta Physiol. Oxf 200 (2010), 11–22.
17. de Simone, G., Devereux, R.B., Chinali, M., Lee, E.T., Galloway, J.M., Barac, A., et al. Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J. Hypertens. 28 (2010), 353–360.
18. Devereux, R.B., Roman, M.J., Paranicas, M., O'Grady, M.J., Lee, E.T., Welty, T.K., et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101 (2000), 2271–2276.
19. Di Bonito, P., Cuomo, S., Moio, N., Sibilio, G., Sabatini, D., Quattrin, S., et al. Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration. Diabet. Med. 13 (1996), 321–324.
20. Djouadi, F., Weinheimer, C.J., Saffitz, J.E., Pitchford, C., Bastin, J., Gonzalez, F.J., et al. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice. J. Clin. Invest. 102 (1998), 1083–1091.
21. Dufour, C.R., Wilson, B.J., Huss, J.M., Kelly, D.P., Alaynick, W.A., Downes, M., et al. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab. 5 (2007), 345–356.
22. Duncan, J.G., Fong, J.L., Medeiros, D.M., Finck, B.N., Kelly, D.P., Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation 115 (2007), 909–917.
23. el Azzouzi, H., Leptidis, S., Bourajjaj, M., Armand, A.S., van der Nagel, R., van Bilsen, M., et al. Peroxisome proliferator-activated receptor (PPAR) gene profiling uncovers insulin-like growth factor-1 as a PPARalpha target gene in cardioprotection. J. Biol. Chem. 286 (2011), 14598–14607.
24. Enguix, N., Pardo, R., Gonzalez, A., Lopez, V.M., Simo, R., Kralli, A., et al. Mice lacking PGC-1beta in adipose tissues reveal a dissociation between mitochondrial dysfunction and insulin resistance. Mol. Metab. 2 (2013), 215–226.
25. Fang, Z.Y., Prins, J.B., Marwick, T.H., Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25 (2004), 543–567.
26. Finck, B.N., Lehman, J.J., Leone, T.C., Welch, M.J., Bennett, M.J., Kovacs, A., et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109 (2002), 121–130.
27. Finck, B.N., Han, X., Courtois, M., Aimond, F., Nerbonne, J.M., Kovacs, A., et al. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 1226–1231.
28. Herrero, P., Peterson, L.R., McGill, J.B., Matthew, S., Lesniak, D., Dence, C., et al. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J. Am. Coll. Cardiol. 47 (2006), 598–604.
29. Huang da, W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4 (2009), 44–57.
30. Huss, J.M., Torra, I.P., Staels, B., Giguere, V., Kelly, D.P., Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell Biol. 24 (2004), 9079–9091.
31. Kwon, D.H., Eom, G.H., Kee, H.J., Nam, Y.S., Cho, Y.K., Kim, D.K., et al. Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4. J. Mol. Cell Cardiol. 65 (2013), 88–97.
32. Lehman, J.J., Barger, P.M., Kovacs, A., Saffitz, J.E., Medeiros, D.M., Kelly, D.P., Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106 (2000), 847–856.
33. Leone, T.C., Weinheimer, C.J., Kelly, D.P., A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 7473–7478.
34. Li, R.J., Yang, J., Yang, Y., Ma, N., Jiang, B., Sun, Q.W., et al. Speckle tracking echocardiography in the diagnosis of early left ventricular systolic dysfunction in type II diabetic mice. BMC Cardiovasc Disord., 14, 2014, 141.
35. Mandel, M.A., Mahmoud, A.A., Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J. Immunol. 120 (1978), 1375–1377.
36. Mazumder, P.K., O'Neill, B.T., Roberts, M.W., Buchanan, J., Yun, U.J., Cooksey, R.C., et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53 (2004), 2366–2374.
37. Nicolino, A., Longobardi, G., Furgi, G., Rossi, M., Zoccolillo, N., Ferrara, N., et al. Left ventricular diastolic filling in diabetes mellitus with and without hypertension. Am. J. Hypertens. 8 (1995), 382–389.
38. Pardo, R., Enguix, N., Lasheras, J., Feliu, J.E., Kralli, A., Villena, J.A., Rosiglitazone-induced mitochondrial biogenesis in white adipose tissue is independent of peroxisome proliferator-activated receptor gamma coactivator-1alpha. PLoS One, 6, 2011, e26989.
39. Planavila, A., Iglesias, R., Giralt, M., Villarroya, F., Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc Res. 90 (2010), 276–284.
40. Regan, T.J., Lyons, M.M., Ahmed, S.S., Levinson, G.E., Oldewurtel, H.A., Ahmad, M.R., et al. Evidence for cardiomyopathy in familial diabetes mellitus. J. Clin. Invest. 60 (1977), 884–899.
41. Rijzewijk, L.J., van der Meer, R.W., Smit, J.W., Diamant, M., Bax, J.J., Hammer, S., et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J. Am. Coll. Cardiol. 52 (2008), 1793–1799.
42. Rubler, S., Dlugash, J., Yuceoglu, Y.Z., Kumral, T., Branwood, A.W., Grishman, A., New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 30 (1972), 595–602.
43. Schreiber, S.N., Knutti, D., Brogli, K., Uhlmann, T., Kralli, A., The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 278 (2003), 9013–9018.
44. Semeniuk, L.M., Kryski, A.J., Severson, D.L., Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am. J. Physiol. Heart Circ. Physiol. 283 (2002), H976–H982.
45. Zhang, Y., Ma, K., Sadana, P., Chowdhury, F., Gaillard, S., Wang, F., et al. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J. Biol. Chem. 281 (2006), 39897–39906.
46. Zhou, Y.T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 1784–1789.